CENTENE CORPORATION Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value
CENTENE CORPORATION (CNC) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value of $66.52 per share for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-17.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue · last filed 2026-02-17
- CENTENE CORPORATION share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2025 was $66.52, a 6.15% decline from fiscal 2024.
- CENTENE CORPORATION share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2024 was $70.88, a 0.51% decline from fiscal 2023.
- CENTENE CORPORATION share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2023 was $71.24, a 1.22% increase from fiscal 2022.
- CENTENE CORPORATION share-based compensation arrangement by share-based payment award, equity instruments other than options, forfeitures, weighted average grant date fair value for fiscal 2022 was $70.38, a 15.47% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Forfeitures, Weighted Average Grant Date Fair Value 12 month |
|---|---|
| 2025-12-31 | $66.52 10-K · filed 2026-02-17 |
| 2024-12-31 | $70.88 10-K · filed 2025-02-18 |
| 2023-12-31 | $71.24 10-K · filed 2024-02-20 |
| 2022-12-31 | $70.38 10-K · filed 2023-02-21 |
| 2021-12-31 | $60.95 10-K · filed 2022-02-22 |
| 2020-12-31 | $60.16 10-K · filed 2021-02-22 |
| 2019-12-31 | $51.11 10-K · filed 2020-02-18 |
| 2018-12-31 | $32.45 10-K · filed 2019-02-19 |
| 2017-12-31 | $20.40 10-K · filed 2018-02-20 |
| 2016-12-31 | $47.65 10-K · filed 2017-02-21 |
| 2015-12-31 | $34.10 10-K · filed 2016-02-22 |
| 2014-12-31 | $23.77 10-K · filed 2015-02-23 |
| 2013-12-31 | $38.91 10-K · filed 2014-02-21 |
| 2012-12-31 | $35.84 10-K · filed 2013-02-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |